IP Library › Assignment 035478/0713
Patent Assignment
Reel/Frame 035478/0713

Merger

Recorded: 2015-04-23 Pages: 103
Assignor
CGI PHARMACEUTICALS, INC.
Executed: 2010-06-23
Assignee
GILEAD CONNECTICUT, INC.
C/O GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA, 94404
Covered Property (1)
SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS SYK INHIBITORS
Patent: 9,567,348 →
Application: 14/629,390 →
Publication: US 2015/0266902
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 23, 2015
From: MITCHELL, SCOTT A.; CURRIE, KEVIN S.; BLOMGREN, PETER A.; KROPF, JEFFREY E.
To: CGI PHARMACEUTICALS, INC.
Reel/Frame 035478/0682 →
Merger and Change of Name Sep 17, 2020
From: COUGAR MERGER SUB, INC.; CGI PHARMACEUTICALS, INC.; CGI PHARMACEUTICALS, INC.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 053799/0190 →
Assignment of Assignor's Interest Sep 30, 2020
From: GILEAD CONNECTICUT, INC.
To: KRONOS BIO, INC.
Reel/Frame 053927/0969 →